In this article
Weight-loss drugmakers Eli Lilly
and Novo Nordisk
fell after telehealth company Hims & Hers
announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
In this article
Weight-loss drugmakers Eli Lilly
and Novo Nordisk
fell after telehealth company Hims & Hers
announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.

Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market

Hims & Hers abandons copycat weight-loss drug in face of FDA probe

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

La empresa de telesalud Hims planta cara a Novo Nordisk con su propia versión del Wegovy por 49 dólares al mes, un tercio del precio de su rival

Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false…

Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.

Shares of Hims & Hers jumped as much as 55% Monday after Novo Nordisk announced it is dropping its lawsuit over Ozempic and…

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap…

Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the…